Loading the state's markets…
Loading the state's markets…
Loading the market…
Medicare market size, surgeons and outlook to 2030
Medicare fee-for-service kyphoplasty & vertebroplasty cases in Idaho: reported (2020, the pandemic year, left out of the line), then forecast with its 80% range. One year ahead, this procedure’s market forecast has been off by 8% on average (184 state-years, 2020–2024): read it as a direction with a margin.
| Year | Surgeons | Medicare FFS | Advantage share |
|---|---|---|---|
| 2019 | 3 | 332 | 37% |
| 2020 | 2 | 235 | 40% |
| 2021 | 1 | 242 | 43% |
| 2022 | 1 | 252 | 47% |
| 2023 | 2 | 212 | 50% |
| 2024 | 3 | 261 | 52% |
| 2025 from claims | – | 366 296–430 | 54% |
| 2026 forecast | – | 415 325–521 | 49% |
| 2027 forecast | – | 432 320–571 | 49% |
| 2028 forecast | – | 449 318–620 | 49% |
| 2029 forecast | – | 468 318–670 | 49% |
| 2030 forecast | – | 487 319–722 | 48% |
Vertebral compression fracture augmentation; IR, pain, spine surgeons. Professional codes (what the surgeon bills): CPT 22513, 22514, 22510, 22511.
Surgeons and fee-for-service cases are from CMS’s Medicare Physician & Other Practitioners files, counted where the surgeon billed; state totals include the cases CMS leaves out of the surgeon-level file (under 11 patients). All Medicare adds patients in Medicare Advantage at the state’s enrollment share; all payers scales Medicare by its share of the procedure nationally. The forecast carries cases per resident 65+ forward with the Census projection of residents 65+. How the numbers are made · Data sources
The 10 busiest do 100% of the cases CMS names in Idaho; 2 surgeons do 80% of them.
MedaRep names every one, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
In 2025, 24% inpatient hospital, 76% hospital outpatient. The share outside the hospital has moved −23 pts since 2019.
| State | Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast |
|---|---|---|---|---|---|---|
| California | 23 | 2,826−4.2%/yr | −4.2%/yr | 0.8 | 27% | 3,540 in 2030+3.8%/yr |
| Arizona | 15 | 1,110+2.9%/yr | +2.9%/yr | 1.5 | 90% | 1,600 in 2030+6.3%/yr |
| Washington | 8 | 686−4.6%/yr | −4.6%/yr | 0.9 | 43% | 570 in 2030−2.9%/yr |
| Colorado | 0 | 538−5.5%/yr | −5.5%/yr | 1.1 | 18% | 560 in 2030+0.6%/yr |
| Utah | 8 | 520−2.1%/yr | −2.1%/yr | 2.3 | 89% | 620 in 2030+3%/yr |
| Oregon | 0 | 181−0.7%/yr | −0.7%/yr | 0.4 | 100% | 310 in 2030+9.2%/yr |
| Nevada | 0 | 169−17%/yr | −17%/yr | 0.6 | 32% | 230 in 2030+5.1%/yr |
| New Mexico | 1 | 106−5.5%/yr | −5.5%/yr | 0.5 | 0% | 90 in 2030−3.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Lumbar fusion | 21 | 882+2.3%/yr | +2.3%/yr | 4.21.5× | 2% | 1,290 in 2030+6.6%/yr |
| Decompression & minimally invasive spine | 23 | 876−1.5%/yr | −1.5%/yr | 4.21.3× | 1% | 1,130 in 2030+4.3%/yr |
| Cervical fusion & disc arthroplasty | 8 | 341−3.9%/yr | −3.9%/yr | 1.61.3× | 0% | 450 in 2030+4.8%/yr |
| SI joint fusion | 2 | 102+43%/yr | +43%/yr | 0.52.1× | 0% | 170 in 2030+8.4%/yr |
Kyphoplasty & vertebroplasty in every state, and its device makers · Every procedure market in Idaho · Every state · Compare with California
VB Spine leads with 69% of company spending on these surgeons in 2025, +19 pts on 2024.
In 2025, 3 companies reported engagement with Idaho’s surgeons worth $24K in consulting, speaking, meals and travel tied to these products, about $8,106 per surgeon billing it. Royalties are left out.
FDA, last 12 months: 1 clearance or approval in the category.
Which surgeons each company engages, and the dollars reported, are in the ranking. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing. Every company in the category.
Share of the cases CMS names by surgeon, by where they billed. Open one for its ranking.